Filing Flows › BioAge Labs (BIOA) › Q1 2026
BioAge Labs (BIOA) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 8, 2026
BioAge Labs (BIOA) reported revenue of $2.8M for the first quarter 2026 (Q1 2026), +91% from a year earlier and -10% from the quarter before. Operating margin was -915.4%, net loss $22.3M (802.8% of revenue).
BioAge Labs, Q1 2026: revenue $2.8M (+91% year over year), operating margin -915.4%, net loss $22.3M, operating cash flow −$24.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | -10% | +91% |
| Operating profit | −$25.4M | — | — |
| Net earnings | −$22.3M | — | — |
| Operating cash flow | −$24.0M | — | — |
What changed
Revenue was $2.8M in Q1 2026, up 91% year over year and down 10% from the previous quarter.
Operating costs exceeded revenue by $25.4M, an operating margin of -915.4%. Total costs grew 57% against revenue growth of 91%. The fastest-growing cost line was Research & development (+84%). The quarter ended with a net loss of $22.3M, narrower than the previous quarter's $25.9M loss.
Operating cash flow was −$24.0M. Non-cash charges added back $4.3M of share-based compensation. Working capital and other items used $6.0M. Capital expenditures of $26K exceeded it, leaving free cash flow of −$24.1M.
Questions
What was BioAge Labs' revenue in the first quarter 2026?
BioAge Labs (BIOA) reported revenue of $2.8M for the first quarter 2026 (Q1 2026), +91% from a year earlier and -10% from the quarter before.
Was BioAge Labs profitable in the first quarter 2026?
Operating loss was $25.4M (-915.4% of revenue) and net loss $22.3M.
Source: BioAge Labs 10-Q on SEC EDGAR.